| CAS No. | CATO-C4X-2007140 |
| Molecular Formula | C7H14Br2 |
| Molecular Weight | 257.99 g/mol |
| Category | Pharmacopoeial Impurity Standards / EP Impurities |
| Availability | In Stock |
Under current pharmacopoeial and regulatory frameworks, quality-control requirements for this class of reference material explicitly involve the control of targets including Brivaracetam Impurity 140.
Brivaracetam Impurity 140 (CAS CATO-C4X-2007140) is a certified pharmaceutical impurity reference standard with the molecular formula C7H14Br2 and a molecular weight of 257.99 g/mol.
Owing to bromine substitution, Brivaracetam Impurity 140 is typically white to off-white crystalline powder. Its solid-state physicochemical attributes — including a molecular weight of 257.99 g/mol — guide the selection of appropriate sample preparation and analytical techniques. Halogen substitution (F/Cl/Br/I) produces a distinctive isotope pattern in mass spectrometry, a valuable aid for qualitative confirmation.
This reference standard supports related-substances testing and method development in line with ICH Q3A/Q3B guidance on impurity control, and is suitable for system suitability testing and forced-degradation studies.
The assigned purity is verified by mass-balance and quantitative NMR (qNMR) approaches, with the expanded uncertainty reported at a 95% confidence level (k=2). Batch homogeneity and stability are independently assessed for every lot.
| Molecular Formula | C7H14Br2 |
| Molecular Weight | 257.99 g/mol |
| Purity | 97%+ |
| Storage | Store at room temperature, keep tightly closed to prevent evaporation |
| Solubility (reference) | Soluble in methanol, acetonitrile, DMSO |
| Stability | Stable under recommended storage conditions |
| Degree of Unsaturation (DBE) | 0.0 |
| Halogen Content | Br-containing |